STOCK TITAN

Evogene chairman Nir Nimrodi gives resignation notice

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
6-K

Rhea-AI Filing Summary

Evogene Ltd. (EVGN) said Nir Nimrodi, chairman of its board, notified the board on November 13, 2026, that he was resigning as a director and chairman. The company said his resignation was not related to any disagreement about its operations, policies or practices.

foreign private issuer regulatory
"REPORT OF FOREIGN PRIVATE ISSUER"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
incorporated by reference regulatory
"incorporated by reference into the registration statements"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who resigned from EVGN’s board, and when?

Nir Nimrodi, chairman of Evogene’s board, notified the board on November 13, 2026, that he was resigning as a director and chairman. The company said the resignation was not related to any disagreement about its operations, policies or practices.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

 

 

UNITED STATES

 SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER 

PURSUANT TO RULE 13a-16 OR 15d-16 OF 

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of November 2026

 

Commission File Number: 001-36187

 

EVOGENE LTD.

  (Translation of Registrant’s Name into English)

13 Gad Feinstein Street, Park Rehovot, Rehovot 7638517, Israel

 

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒       Form 40-F ☐

 

 

CONTENTS

 

Resignation of Director

 

On November 13, 2026, Mr. Nir Nimrodi, chairman of the board of directors (“Board”) of the Company, has notified the Board of his resignation from his position as a member and chairman of the board of directors. Mr. Nimrodi’s resignation was not related to any disagreement with the Company on any matter relating to its operations, policies or practices.

 

The content of this Form 6-K is incorporated by reference into the registration statements on Form F-3 (Securities and Exchange Commission File No.’s 333-277565 and 333-294650), and Form S-8 (SEC File No.’s 333-193788, 333-201443, 333-203856, 333-259215, 333-286197 and 333-294648) of the Company, filed with the Securities and Exchange Commission, to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 




Date: November 16, 2026
EVOGENE LTD.
(Registrant)

By: /s/ Ofer Haviv
Ofer Haviv
Chief Executive Officer

 

 

 

Keep reading